Meet the Judges

Entries will be judged by a senior panel of accomplished judges from across Advanced Therapies. Judges are formed of biotechs, academics, investors and leading vendors and all entries will be subject to a two-stage judging process.

CEO Bone, Therapeutics

Dr. Forte has significant experience in regenerative medicine and in the cell therapy industry, most recently as Chief Execu…

Executive Director, Harvard Stem Cell Institute

As Executive Director of HSCI, Brock Reeve works in partnership with the Faculty Directors, and has overall responsibility f…

CEO, OX2 Therapeutics

Jeff is a seasoned CEO with a proven track record at profitably growing emerging companies and bu…

Founder and Executive Chairman, Akron

With over 30 years of experience in the regenerative medicine industry, Dr. Zylberberg has established herself as a leader i…

CSO, INmune Bio

Prof. Lowdell has been a Chief Scientific Officer and Chief Manufacturing Officer since the formation of INmune Bio in Septe…

CEO, Adva Therapeutics

Dr Karnieli is the Founder and President of Atvio Biotech and Adva Biotechnology. Former VP of Technology & Manufacturin…

Co-Founder and Executive Managing Director, Centre for Breakthrough Medicines

Audrey Greenberg is Co-founder of the Center for Breakthrough Medicines and Discovery Labs where …

CEO, Antion Biosciences

Dr Sven Kili is Chief Executive Officer at Antion Biosciences, a Multiplex Cell Engineering company developing ‘Smart-Data’ …

President and COO Rocket Pharma

Kinnari Patel is President & Chief Operating Officer for Rocket Pharma. She oversees IT, HR, regulatory, clinical execut…

CEO, Propel Biosciences

Susan is CEO of Propel BioSciences Inc. where she leads a team who support the business development, drug development and fr…

President Dark Horse Consulting
Founder, Emily Whitehead Foundation

Tom Whitehead is a keynote speaker, author, and journeyman lineman for Penelec, a FirstEnergy Company. He is also the proud …

Professor, Upenn

Dr. Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, is the Founding Director of the Clinical Cell …

CEO, Atara Biotech

With more than 30 years of global biopharmaceutical leadership experience, Pascal Touchon joined Atara Biotherapeutics as Pr…

Professor of Molecular Medicine, National Heart and Lung Institute, Imperial College

Uta Griesenbach is a Professor of Molecular Medicine at the National Heart and Lung Institute, Imperial College London. She …

EVP, Chief Medical Officer, Leukemia and Lymphoma Society

As The Leukemia & Lymphoma Society’s (LLS) Chief Medical Officer (CMO), Gwen Nichols, M.D., plays a critical role …

Chief Technology Officer , Triumvira Immunologics

Ms. Rill joined Triumvira as Chief Technology Officer in June 2018. Prior to Triumvira, Ms. Rill, an accomplished expert in …